Rockland Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $248K | Sell |
1,965
-14
| -0.7% | -$1.84K | 0.01% | 293 |
|
|
2026
Q1 | $276K | Buy |
1,979
+99
| +5% | +$13.9K | 0.01% | 283 |
|
|
2025
Q4 | $231K | Buy |
1,880
+7
| +0.4% | +$851 | 0.01% | 290 |
|
|
2025
Q3 | $208K | Buy |
1,873
+7
| +0.4% | +$796 | 0.01% | 293 |
|
|
2025
Q2 | $207K | Sell |
1,866
-25
| -1% | -$2.66K | 0.01% | 254 |
|
|
2025
Q1 | $212K | Sell |
1,891
-2,879
| -60% | -$297K | 0.01% | 259 |
|
|
2024
Q4 | $441K | Sell |
4,770
-175
| -4% | -$15.8K | 0.02% | 195 |
|
|
2024
Q3 | $415K | Sell |
4,945
-33
| -0.7% | -$2.52K | 0.02% | 201 |
|
|
2024
Q2 | $342K | Buy |
4,978
+471
| +10% | +$31.4K | 0.02% | 236 |
|
|
2024
Q1 | $330K | Sell |
4,507
-69
| -2% | -$5.31K | 0.02% | 238 |
|
|
2023
Q4 | $371K | Sell |
4,576
-34
| -0.7% | -$2.65K | 0.02% | 226 |
|
|
2023
Q3 | $345K | Hold |
4,610
| – | – | 0.02% | 221 |
|
|
2023
Q2 | $355K | Hold |
4,610
| – | – | 0.02% | 228 |
|
|
2023
Q1 | $382K | Sell |
4,610
-319
| -6% | -$26.4K | 0.02% | 216 |
|
|
2022
Q4 | $423K | Sell |
4,929
-1,202
| -20% | -$95.2K | 0.03% | 210 |
|
|
2022
Q3 | $379K | Hold |
6,131
| – | – | 0.03% | 196 |
|
|
2022
Q2 | $379K | Hold |
6,131
| – | – | 0.03% | 210 |
|
|
2022
Q1 | $364K | Buy |
6,131
+1,046
| +21% | +$66.9K | 0.02% | 249 |
|
|
2021
Q4 | $369K | Buy |
5,085
+495
| +11% | +$34.1K | 0.02% | 234 |
|
|
2021
Q3 | $321K | Buy |
4,590
+250
| +6% | +$17.6K | 0.02% | 234 |
|
|
2021
Q2 | $298K | Buy |
4,340
+758
| +21% | +$50.6K | 0.02% | 235 |
|
|
2021
Q1 | $232K | Sell |
3,582
-89
| -2% | -$5.74K | 0.02% | 250 |
|
|
2020
Q4 | $214K | Sell |
3,671
-116
| -3% | -$7K | 0.02% | 246 |
|
|
2020
Q3 | $239K | Buy |
3,787
+37
| +1% | +$2.57K | 0.02% | 235 |
|
|
2020
Q2 | $288K | Sell |
3,750
-50
| -1% | -$3.83K | 0.03% | 205 |
|
|
2020
Q1 | $284K | Sell |
3,800
-129
| -3% | -$8.91K | 0.03% | 211 |
|
|
2019
Q4 | $255K | Hold |
3,929
| – | – | 0.02% | 239 |
|
|
2019
Q3 | $244K | Buy |
+3,929
| New | +$257K | 0.02% | 241 |
|
|
2018
Q2 | – | Sell |
-2,731
| Closed | -$206K | – | 205 |
|
|
2018
Q1 | $206K | Sell |
2,731
-150
| -5% | -$11.9K | 0.03% | 200 |
|
|
2017
Q4 | $206K | Sell |
2,881
-200
| -6% | -$15.2K | 0.03% | 202 |
|
|
2017
Q3 | $250K | Sell |
3,081
-1,714
| -36% | -$131K | 0.04% | 146 |
|
|
2017
Q2 | $339K | Sell |
4,795
-173,450
| -97% | -$11.5M | 0.05% | 130 |
|
|
2017
Q1 | $12.1M | Buy |
178,245
+25,551
| +17% | +$1.8M | 1.91% | 17 |
|
|
2016
Q4 | $10.9M | Sell |
152,694
-2,846
| -2% | -$212K | 1.75% | 19 |
|
|
2016
Q3 | $12.3M | Buy |
155,540
+13,433
| +9% | +$1.09M | 2.13% | 15 |
|
|
2016
Q2 | $11.9M | Buy |
142,107
+3,756
| +3% | +$333K | 2.05% | 15 |
|
|
2016
Q1 | $12.7M | Buy |
138,351
+8,329
| +6% | +$751K | 2.28% | 12 |
|
|
2015
Q4 | $13.2M | Buy |
130,022
+3,646
| +3% | +$379K | 2.32% | 13 |
|
|
2015
Q3 | $12.4M | Buy |
126,376
+1,833
| +1% | +$204K | 2.44% | 13 |
|
|
2015
Q2 | $14.6M | Sell |
124,543
-2,468
| -2% | -$270K | 2.89% | 5 |
|
|
2015
Q1 | $12.5M | Sell |
127,011
-2,855
| -2% | -$290K | 2.64% | 11 |
|
|
2014
Q4 | $12.2M | Sell |
129,866
-4,674
| -3% | -$483K | 2.52% | 10 |
|
|
2014
Q3 | $14.3M | Sell |
134,540
-5,125
| -4% | -$502K | 3.15% | 5 |
|
|
2014
Q2 | $11.6M | Buy |
139,665
+3,815
| +3% | +$297K | 2.63% | 11 |
|
|
2014
Q1 | $9.63M | Buy |
135,850
+16,183
| +14% | +$1.27M | 2.26% | 21 |
|
|
2013
Q4 | $8.99M | Sell |
119,667
-20
| -0% | -$1.39K | 2.16% | 18 |
|
|
2013
Q3 | $7.53M | Buy |
+119,687
| New | +$7.15M | 1.99% | 22 |
|
Other funds holding GILD
Rockland Trust's GILD Position: Q2 2026 in Review
Rockland Trust reduced its Gilead Sciences (GILD) stake by 0.71% in Q2 2026, selling an estimated $1.84K and leaving 1,965 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #293.
Rockland Trust first reported a position in GILD in Q3 2013 and has held it in 47 quarters since. The position peaked at $14.6M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Rockland Trust held 1,965 shares of Gilead Sciences worth $248K as of Q2 2026.
- Rockland Trust sold 14 Gilead Sciences shares in Q2 2026, an estimated $1.84K.
- Gilead Sciences made up 0.01% of Rockland Trust's portfolio in Q2 2026, its #293 holding.
- Rockland Trust first reported a position in Gilead Sciences in Q3 2013 and has held it in 47 quarters since.
- Rockland Trust's Gilead Sciences position peaked at $14.6M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.